Dailypharm Live Search Close

PVA guidelines are about to be revised

By Lee, Hye-Kyung | translator Choi HeeYoung

22.01.26 06:00:52

°¡³ª´Ù¶ó 0
Director Lee Sangil, "lower prices as the pharmaceutical industry sells more"

The revision of detailed operational guidelines for PVA is imminent

The NHIS is internally reviewing a revision to the guidelines that includes a 100 ¡æ 90% change in the arithmetic average exclusion standard and a 15 ¡æ 2 billion won increase in the claim exclusion standard from this year's "Type Da" negotiations.



NHIS' Senior director Lee Sangil said at the Korea Special Press Association briefing held on the 25th, "The guidelines amendment is currently under internal review and will be revised so that it can be applied from this year's Type Da negotiations." On December 2 of last year, the NHIS announced a plan to improve the PVA negotiation system at the 10th public-private consultative body involving the MOHW, the NHIS, the HIRA, KRPIA, and KPBMA.

Ac

Lee, Hye-Kyung(hgrace7@dailypharm.com)
If you want to see the full article, please JOIN US (click)